This inventor holds 1 USPTO granted patent. Top assignee: Regulaxis. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Raffaello Paolini and His Osteoarthritis Treatment Patent
Introduction
Raffaello Paolini is an inventor associated with Paris, France, and the biotechnology company Regulaxis. His patent work focuses on a peptide-based approach to treating osteoarthritis.
Latest Patents
Paolini is listed as an inventor on 1 patent: “Methods for Treating Osteoarthritis by Administering Linked Variants of Growth Hormone and Somatostatin.” The disclosure describes peptides that include the sequence SEQ ID NO: 1 for use in treating osteoarthritis.
Career Highlights
Paolini’s listed invention addresses osteoarthritis through the administration of linked variants of growth hormone and somatostatin. The patent connects his work with research and development at Regulaxis.
Collaborations
Paolini’s listed coworkers include Claude Carelli and Christelle Vêtu.
Conclusion
Raffaello Paolini’s patent record highlights his contribution to research into peptide-based approaches for osteoarthritis treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile